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All'long calmodulin.non-binding glycosphingolipids, GM3, sialosylneolactotetraosyleeramide (LM 1), and sulfatide potently activated ¢almodulin- 
dependent cyclic nucleotide phosphodiesterase with or without Ca :+ showing ED~o 1-5 ltM. In contrast o ¢almodulin-binding gangliosides, these 
glycosphingolipids activated the enzyme up to the maximum level achieved by Ca'-Vcalmodulin and did not inhibit the activity at higher 
concentrations. Competition studies with GD I b that bind both to cahnodulin and the enzyme suggest that the calmodulin-aon-bindinf~ glyeosphi,i- 
8olipids acti,Jate the enzyme through interaction with the same site of the enzyme as GDI b interacts. 
GM3; LMI; Sulfatlde; Ganglioside; Calmodulin; cAMP-phosphodiesterase 
1. INTRODUCTION 
Gangliosides with a gangliotetraose core and GM2 
were shown in our previous studies to inhibit a CaM- 
dependent enzyme, cyclic nucleotide phosphodiesterase 
(PDE), through binding to CaM and the enzyme [3,4]. 
CaM is expressed in all eukaryotic cells and is essential 
to calcium signal transduction by modulating a wide 
variety of enzymes. Gangliosides are present in all verte- 
brates and higher invertebrates and it is proposed that 
they modulate several cellular activities [5]. Gangli- 
oside-mediated modulation of cell activities via a CaM- 
mediated signal transduction pathway has thus been put 
forward [4], 
In non-neural tissues, such a ganglioside-mediated 
modulation could hardly be expected since CaM-bind- 
ing gangliosides are usually not abundant in these tis- 
sues. However, GM3 and neolacto series gangliosides 
instead are abundant in these tissues and these gangli- 
osides, when given exogenously to the cells, modulate 
cellular activities such as differentiation and prolifera- 
tion in a variety of non-neural and neural cells [6-13]. 
The gangliosides may regulate these cellular activities 
by modulating transmembrane signal transductions 
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Abbreviations:CaM, calmodulin; dansyl, 5-dimethylamiuonaph- 
thalene-l-sulfonyl; ]PDE, cyclic nucleotide phosphodiesteras¢. Abbre- 
viations by Svennerholm [ 1] for ganglio.sid~s and IU PAC-I U B R~.~om- 
mendations for lipids [2] were u~ed: GDIb, ii-~(NeuAca2-8NeuAc}- 
GlhCer; LMI, sialosylneolactotetraosyleeramid¢, IWSia!yl-nLc,Cer. 
Structures of the other glycosphingolipids are shown in Table I. 
through binding to certain molecules although until 
now there has been no evidence of direct interaction of 
these gangliosides with such molecules. In this study, we 
have investigated the effects of these and other glyco- 
splnngolipids on a typical CaM-dependent enzyme, 
PDE. Among them thus far tested, GM3, LMI, and 
sulfatide activated PDE, up to the maximum level 
achieved by Ca-'+/CaM-activation. These effects were 
compared with those of Caa+/CaM and CaM-binding 
gangliosides on the enzyme and it is proposed that these 
CaM-no~-binding glycosphingolipids activate the en- 
zyme through interacting with a site other than CaM- 
binding site of the enzyme, the same site as CaM-bind- 
ing gangliosides interact. 
2. MATERIALS AND METHODS 
2. I. Materials 
Cyclic AM P, snake venom from Crotalus atrox activator deficient 
3',5"-cyclic nucleotide phosphodiestera~¢ from bovine brain (I)-9529), 
and bovine brain CaM were purchased from Sigma, St. Louis, MO. 
GM3, GM3(NeuGc), LMI{NeuGe). NeuGc.nL%Cer, nLc~Cer and 
Gal-nl.xaCer were prepared as already described [14]. GalCer and 
sulfatide and Gg~Cer were prepared from bovine brain as already 
de~erib~ [41. 4-O-Ac-GM3(NeuGe) was prepared as already de- 
scribed [15]. LaeCer was prepared from equine erythroeytes using 
latrobeads column chromatography b  the method escribed previ- 
ously [15]. GDIb was purehasexl from latron Lab., Tokyo, Japan. 
2.2. Phosl~hodlesteraae assay 
The Cheung method [16] was used with a slight modifim~tion as 
described previously [3]. For an assessment ofthe effect of the enzyme 
reaction by 81ycosphingolipids, the glyeosphingolipids were added at 
an appropriate conczntr~tfio,n ,o '.he ine,-,bafion mixture consisting of 
cAMP and PDE. Little, if any CaM-independent phosphodiesterase 
activity could be detected ia the enzyme preparation, 
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Fig, I. Effects of glycosphin/golipids on CaM-dependent phospho- 
die~terase. Dif&rent glyeon~hiagolipid~ at variotts coaceau~t/.oas 
were added to reaction mixtures of phosphodiesterase without CaM, 
Activity is expressed as activity relative to maximum activity stimu- 
lated by Ca: ' /CaM. 
Trypsin-treatment of pho~phodiesterase was performed by the 
method of Davis and Daly [171 with a modification as already de- 
scribed [4]. 
2,3. Other niethods 
Lipid-bound .~ialic acids were measured b~' the method of Jourdi;m 
et ah [ 18], 
3. RESULTS 
3.1, Effects of  variotts glycosph&gotipicls on PDE 
GM3, LM 1, and sulfatide activated the enzyme in the 
absence of CaM (Fig. 1). The activation was Ca -~* inde- 
pendent (data not shown), Besides GM3 and suifatide 
[3,4], LM1 showed no effect on Ca:*/CaM-activated 
PDE or fluorescence spectrum ofdansyl-CaM (data not 
shown), intJica~tin~ ,ba~ ~z aJso d~d not b)nd zo CaM, As 
shown in "I'able l, ED~o of zhese g}ycosphJngolip)ds were 
1-5/,tM. Higher concentrations were required for acti- 
vation compared to gangliosides that interact with both 
be emphasized that they showed no inhibition at all 
even at higher concentrations. They were thus shown to 
act as CaM agonists to PDE though higher concentra- 
tions by three orders of  magnitude are required com- 
pared to CaM. Now, we would like to classify these 
glycosphingolipids to Group 3 glyeosphingolipids. 
GM3 derivatives were examined with special refer- 
enee to sialyl residues. NeuAc was found to be slightly 
more efficient han NeuGe which was followed by O- 
aeetylation at 4 position of sialyl residue (Fig. 1 and 
Table 1). 
The efficiency of NeuGc-nLc~Cer which has a longer 
sugar chain than LM l(NeuGc) was remarkably dimin- 
ished, showing nine times as much as ED~0 of LM1 
while LMl(NeuGc) was slightly more effective than 
GM3(NeuGe) (Table I). Neutral glycosphingolipids, 
nLe.)Cer and GgaCer showed activation to some extent 
even though their efficiency was less than 1/10 that of 
their sialyl derivatives. Gal-nLc#Cer, Gb4Cer, LacCer, 
and GalCer showed little, if any, effect. 
3.2. EJfects of  Group 1 gangliosMes on PDE activio; 
stimtdated by Group 3 glyco,~TJh&golipkls 
Ca'-*/CaM-stimulated PDE activity was shown in the 
previous tudy to be inhibited by Group 1 gangliosides 
such as GDIb [4]. GDIb showed inhibition even at the 
concentrations where it showed activation of the en- 
zyme in the absence of CaM. Excess CaM overcame 
inhibition. To compare the nature of PDE stimulation 
by Group 3 glycosphingolipids with that by Ca-'*/CaM, 
the effects o fGD I b on the glycosphingolipid-stim ulated 
enzyme activity were examined. Fig. 2 shows the effects 
of GDIb on LM l(NeuGc)-stimulated PDE. The activ- 
ity stimulated by LMI(NeuGc) at the concentrations 
above )DbtM was )nh)b)ted by ODlb  at a)l the concen- 
• ,rat)ons z~e~. lnh)bk)on was manifest even az the con- 
centrations where GDIb showed activation of the en- 
zyme in the absence of other stimulators, while the ac- 
Table I 
Stimulative ffects of glycosphingolipids on phosphodiesterase 
(pM) 
GM3(NeuA¢) NeuAc~2 --, 3Ga~l  ---> 4GIc-Cer 1,2 
GM3(NeuGc) NcuGc0c2 ~ 3Galfll -~ 4Glc-Ccr 2.9 
4-O-Ac-GM3(NeuGc) 4-O-AcelyI.NeuGc~2 .--93Galfll --* 4Glc-Cer 4,1 
LM l{NeuGc) NeuGc~2 --) 3G.'dfll ~ 4GlcNAcfll --~ 3Galfll --> 4Gle.Cer 2.4 
Sulfatid~ I-I,SO.a --~ 3GaI-Cer 4,5 
nLc,~Cer Galfll -~ 4GIcNAcfll -~ 3Gal//l --~ 4GIc-Cer 30 
Oal-nLc4Cer Galczl --~ 3Oalfll -+ 4GlcNAcfll - )  3Galfll ~ 4Olc-Cer > 100 
G&~Cer Galffl -+ 3GalNA¢~I --~ 4Gal~l -~ 4Glc-Cer 24 
Gb.~Cer OalNAcfll ~ 3Gakzl --* 4Galpl ---> Glc.Cer > 100 
La¢Cer Gal,fll ~ 4GIc-Cer > i00 
Owi~ ~ ~a'?-~.~.a- > 100 
5,~ 
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Fig, 2. Effects of GDIb  on LMl(NeuOc)-stimulated phospho. 
diestera~e activity, Various concentration~ of GDIb were added to 
reaclion mixtures o1" pJ~osphodies~erase stJmulat-*d by lhc iadicnled 
concentrations of LMi(NeuGc). Activity is expressed as activity rein. 
tire to that stimulated by 45 tim LMI(NeuGc) without GDIb, 
concentration (below 1 pM) of GD I b. Direct inhibition 
of the enzyme activity by G D lb shown at the concentra- 
tions above 1 /aM was eliminated by excess 
LMI(NeuGc). Similar results were obtained using 
GM3(NeuGc) or sulfatide instead of LMI(NeuGc) 
(data not shown). Their activation properties were thus 
shown to be very similar to Ca-'*/CaM (refer to Fig. I C 
in [4]). 
To investigate further a relationship between activa- 
tion by LMI and inhibition by GDlb, activation of 
PDE by LMI(NeuGc) in the presence of GDlb at inhib- 
iting concentrations was examined. The Lineweaver- 
Burk plots indicate it to be a competitive inhibition with 
a constant maximum activity and increasing ED~(, cor- 
responding to GDlb concentration (Fig. 3). Thus 
GDIb was shown to inhibit the enzyme by competing 
w~th LMI(NeuGc). A'i of  GDlb  was ca)culated as ~.6- 
2.8/zM. The above results suggest hat an LMl-inter- 
°1/.. I 
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Fig. 3. Inhibition by GDIb  on LMl(NeuGe)-stimulation of 
pho~phodiesterase ctivity. Activation b~ LM l(NeuGc) of phozpho- 
diesterase was a~es.~cd in the presence oflndicated conccntration~ of 
GDI b, Activation b), LM 1 (NeuGc) alone was measured for the con- 
trol. Activity (v) i~ expressed as rclativ~ activity to maximum activity 
are shown. 
acting site of the enzyme is either the GD I b-interacting 
site or CaM-binding site. 
3.3. Effects of Group 3 glycosphingolipids on trypsin- 
activated PDE 
To determine whether LM1, GM3, and sulfatide in- 
teract with the CaM-binding site or the same site as 
GDIb does, the effects of these glycosphingolipids on
tt3,psin-treated PDE, which has lost CaM-binding do- 
main and expressed full activity without CaM, were 
examined. The three glycosphingolipids showed no ef- 
fect on the trypsin-activated nzyme (data not shown). 
However, they reversed inhibition by GDIb of the tryp- 
sin-activated nzyme activity (Fig. 4). These results indi- 
cate that they interact either with GDIb or the same site 
of the enzyme as GDlb does, which is presumably dif- 
ferent from the CaM-binding site, to recover the activ- 
ity. Since they failed to increase the fluorescence inten- 
sity of dansyl-CaM by GDIb (data not shown), it is 
likely they did not interact directly with GD 1 b. It is thus 
suggested that these glycosphingolipids nteract with the 
same sile as GDlb does. 
4. DISCUSSION 
CaM-binding gangliosides are classified into two 
groups according to their effects on PDE [4]: Group 1 
gangliosides such as GDlb, GTIb, and GDIa show 
strong direct activation and inhibition of the enzyme; 
Group 2 gangliosides such as GMI, GM2, and GQlb 
show little direct inhibition of the enzyme. As shown in 
the present study, GM3, LML and sulfatid~ did not 
bind to CaM showing only a positive ffect on the en- 
zyme and should thus be classified into another group, 
Group 3. They activated PDE to the maximum )eve) 
achieved by Ca~-+/CaM (Fig. !) and showed no effect on 
Ca2*/CaM-stimulated PDE. PDE activity stimulated by 
Group 3 glycosphingolipids was inhibited by a Group 
t ~,q,al~,qlL~hi~ ~D, kb~.E~q ~) .T.lz,~C~3~.inhihitinp .w.a~ 
co,wirer)Dye w)12~ O/'oz~p 3 g)ycosp)~£o))p),:)s I~F)g. 3j) as 
in the case of inhibition of Ca:VCaM-stimulated n- 
zyme by GDlb where GDIb inhibits the activity com- 
petitively with CaM [4]. Furtherlnore. as in the ease of 
inhibition of CaZ+/CaM-stimulated PDE [4], GDlb, 
e~ea at ~tct~vatktg, coct~rttc~tMrt~. rth~bi~d activity 
stimulated by Group 3 glycosphingolipids (Fig. 2). 
While Group 3 glycosphingolipids showed no effect on 
the activity of trypsin-stimulated PDE, they eliminated 
inhibition by GDI b of trypsin-stimulated enzyme (Fig. 
4). Thus the effects of Group 3 glycosphingolipids on
PDE were quite similar to those of Ca~VCaM. How- 
ever, in contrast o CaM° Group 3 glycosphingolipids 
provided no evidence of binding to GD1 b as described 
above. Thus, it is proposed that the glycosphingolipids 
bind to the same site as GDIb binds, CaM-like binding 
site 0 9~ of the enz~vme for activation. They may release 
a suppressive domain, CaM-binding site from CaM-like 
Volume 314, number 1 FEBS LETTERS December 1992 
A 
E 
.= 
111 
120 
o 
100 " 
, 
60" 
40' 
20' 
_ I c°nr° I 
10 ~M GM'~ 
19 ~aM GM3 
,...-,o 
. . . . . .  i 
1 10 100 
ODlb (laM) 
B 
E 
g; 
120 
100 
a0 
60 
40 
20 
6 laM LM1 
22tam LM1 
451aM LM1 
• - -  . . . . . .  - I  m . . . .  -1  r r l  
'l 10 100 
GDlb (pM) 
C 
itl 
100 
80 
60 
40 
20 
0 
- ~ Contr01 I 
I 
5.4 ~aM Suit. [ 
l 
I 11 JaM ~ull. 
I 
1 10 10o 
GDlb ([aM) 
Fig. 4. Effects on glyeosphingolipids on GDIb inhibition of 
phosphodiesterase ctivated by trypsin-treatment. Various concentra. 
tions ol" GDI b were added io reaction mixtures o1" Ihe trypsin-slim e- 
lated phosphodiesteras¢ in the presence of indicated eoneemrations of 
(A) GM3(NeuGa), (B) LMIfNeuG¢) and (C) sttll'atide. Activity is 
expressed as activity relative to that without gangliosides. The trypsi- 
nized enzyme underwent no change in activity when glycnsphingolip. 
id~ were added alone. 
binding site to activate PDE. They may also release 
GDIb from CaM-like binding site by binding to this site 
competitively with GDlb to eliminate nzyme inhibi- 
tion caused '--'u~ ,,..,~  u . " '~ '  "
The present results suggest hat sialyl residue of the 
Group 3 glycosphingoHpids is not essential but acidic 
group and a certain length of saecharide chain which 
keeps the distance between acidic group and hydropho- 
bic ceramide portion are necessary for the activation, 
since sulfatide was potent ,'activator besides GM3 and 
LMI, and sialyl nL%Cer was much less effective than 
LMI (Table 1). In addition, difference in activation po- 
tential of neutral glycosphingolipids (Table I) indicates 
conformation of saccharide chain may also affect acti- 
vation potency. It is noteworthy that Group 3 glyco- 
sphingolipids are much more efficient han PDE acti- 
vating lipids so far known, such as fatty acids and lyso- 
phospholipids (EDs0=20,uM or more) [20,21]. 
Since in vitro interactions of GM30 LM!, and sulfat- 
ide with PDE have been shown in the present study, in 
vivo interactions of these CaM-non-binding glycosphin- 
golipids and PDE may occur, as has been postulated in 
the case of CaM-binding angliosides and CaM. Some 
glycosphingolipids are reported to be present in cytosol 
[22-27] and oriented to the eytosolic side in a membrane 
[28-31], such glycosphingolipids, therefore° possibly in- 
teract with CaM-dependent enzymes uch as PDE to 
regulate them at low Ca .-'+ concentrations or give some 
bias toward these activities to modulate cell activities. 
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